| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| BeiGene, Ltd. | 10%+ Owner | $20.9M | Sep 24, 2021 | ||
| Gilead Sciences, Inc. | 10%+ Owner | $15.2M | Apr 10, 2024 | ||
| Douglas E. Onsi | CEO,CFO,Pres.,GC,Treas.&Sec., Director | $2.12M | Nov 13, 2024 | ||
| Christopher Mirabelli | Chairman of the Board, Director | $1.93M | Nov 13, 2024 | ||
| Augustine Lawlor | Chief Operating Officer | $1.93M | Nov 13, 2024 | ||
| James Cavanaugh | Director | $739K | Nov 13, 2024 | ||
| John Mark O'Mahony | Chief Manufacturing Officer | $14.3K | Oct 2, 2024 | ||
| Cynthia Sirard | Chief Medical Officer | $14.3K | Oct 2, 2024 | ||
| Joseph Loscalzo | Director | Oct 2, 2024 | |||
| Nissim Mashiach | Director | Oct 2, 2024 | |||
| Christine Granfield | VP, Head of Reg Affairs/Qual | Oct 2, 2024 | |||
| Monica Bertagnolli | Director | Jan 31, 2022 | |||
| Perceptive Advisors Llc | 10%+ Owner | Sep 24, 2021 | |||
| Richard Schilsky | Director | Oct 2, 2024 | |||
| Christian M. Richard | Director | Oct 2, 2024 | |||
| A. Martin | Director | Oct 2, 2024 | |||
| Jason Baum | Chief Scientific Officer | Oct 2, 2024 | |||
| William Li | Director | Oct 2, 2024 | |||
| Thomas Dietz | Director | Oct 2, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|